By Laura Lutz
Washington, Feb. 1 - OccuLogix, Inc. priced a private placement of shares for about $10 million.
The company plans to sell about 6.7 million shares to institutional investors at $1.50 per share.
Investors will also receive about 2.7 million warrants exercisable at $2.20.
Settlement is expected on Feb. 6.
Cowen and Co., LLC will act as placement agent.
Proceeds will be used for general corporate purposes.
OccuLogix is a Boston-based ophthalmic device company.
| Issuer: | OccuLogix, Inc.
|
| Issue: | Shares
|
| Amount: | $10 million
|
| Shares: | 6.7 million
|
| Price: | $1.50
|
| Warrants: | 2.7 million
|
| Warrant strike price: | $2.20
|
| Agent: | Cowen and Co., LLC
|
| Pricing date: | Feb. 1
|
| Settlement date: | Feb. 6
|
| Stock symbol: | Nasdaq: OCCX
|
| Stock price: | $1.85 at close Jan. 31
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
